NeuroMetrix Reports Publication Of Results From DPNCheck Study - Quick Facts

(RTTNews) - NeuroMetrix Inc. (NURO) reported publication of results from a DPNCheck study, titled "Assessment of Diabetic Neuropathy Using a Point-of-Care Nerve Conduction Device Shows Significant Associations With the LDIFLARE Method and Clinical Neuropathy Scoring". DPNCheck is a quantitative point-of-care test for diabetic peripheral neuropathy, or DPN. The company said the findings of the study suggest that the device has considerable potential for assessing DPN in diabetes clinics.

"The impressive diagnostic performance of DPNCheck indicates that it is effective at detecting DPN at all stages of the disease from mild to advanced neuropathy. There is no other widely available diagnostic test for DPN with comparable operating characteristics," said Shai Gozani, CEO of NeuroMetrix.